Full-Time

Senior AI Development Platform Engineer

Lirio

Lirio

51-200 employees

Behavioral-AI health engagement personalisation engine

Compensation Overview

$165k - $185k/yr

No H1B Sponsorship

Tennessee, USA

Hybrid

Initial on-site onboarding in Tennessee; hybrid option for TN residents; travel expenses covered.

Category
DevOps & Infrastructure (2)
,
Required Skills
Kubernetes
Microsoft Azure
Python
Github Actions
Java
Docker
Terraform
Requirements
  • Bachelor's degree in related field
  • 5-7 years of related experience
  • AI-assisted development fluency: Hands-on experience with AI coding tools (Cursor, GitHub Copilot, Claude Code, Codex CLI, or similar). Not just casual use, but experience building workflows, instruction files, or agent orchestration patterns around them.
  • Platform engineering or developer productivity background: Experience building internal developer platforms, CI/CD pipelines, developer tooling, or infrastructure that accelerates how engineering teams deliver software.
  • Compliance in regulated environments: Experience working within HIPAA, HITRUST, SOC 2, or equivalent compliance frameworks. Ability to translate compliance requirements into automated guardrails rather than manual review bottlenecks.
  • Programming proficiency: Strong skills in Java and/or Python (Lirio's primary stack). Ability to work across codebases, write tooling, and understand the code that AI agents produce.
  • Agent orchestration and integration: Familiarity with MCP (Model Context Protocol), LLM APIs, instruction file systems, or similar patterns for configuring and constraining AI agent behavior. Experience building integrations between developer tools and enterprise systems (work item tracking, source control, CI/CD).
  • CI/CD and DevOps proficiency: Strong experience with CI/CD pipelines, automated testing, code review workflows, and deployment automation. Experience with Azure DevOps (ADO) is a plus; GitHub Actions/Workflows experience is also valuable.
  • Security awareness: Understanding of secure software delivery practices, including code scanning, dependency management, access controls, and audit trail requirements in the context of AI-generated code.
  • Bias toward rapid, iterative delivery: This role needs to produce working developer platform capabilities fast, shipping in weeks, learning from real usage, and improving continuously.
  • Experience in healthcare technology or another heavily regulated industry.
  • Familiarity with multi-model AI routing, model benchmarking, or model evaluation frameworks preferred.
  • Experience with infrastructure as code (Terraform), containerization (Docker, Kubernetes/AKS), and cloud platforms (Azure preferred).
  • Demonstrated ability to lead platform adoption and drive organizational change across engineering teams.
  • Technical writing ability
Responsibilities
  • Evaluate and recommend AI coding tools (Cursor, Claude Code, GitHub Copilot, Codex CLI, and emerging tools) against Lirio's developer workflows, compliance constraints, and codebase characteristics.
  • Conduct structured evaluations of new models and tools as they launch, testing against real coding tasks in our environment, not just vendor benchmarks.
  • Maintain the evaluation framework and tooling inventory, ensuring the team uses approved, security-reviewed tools on compliance-sensitive systems.
  • Design and build the agent orchestration layer: instruction files (.cursor/rules/, AGENTS.md, CLAUDE.md), MCP connectors to Azure DevOps and/or GitHub, context packaging templates, and agent routing configurations.
  • Enable AI coding agents to execute multi-step software development tasks autonomously (decompose, plan, code, test, validate, and submit PRs) with quality gates at each phase and defined escalation points.
  • Design agent coordination patterns (planner-coder-reviewer, sub-agent delegation) and workflow state management for complex tasks that span multiple agent steps.
  • Define human escalation triggers so that when agents encounter ambiguity, scope boundaries, or compliance-sensitive decisions, the workflow surfaces the decision to a human rather than guessing.
  • Ensure AI coding agents receive the right context for each task type, including project conventions, compliance constraints, coding standards, and relevant codebase context. Manage context window budgets so agents maintain accuracy across large codebases.
  • Build and maintain work decomposition patterns and templates that structure work items for effective agent execution.
  • Architect integrations between the AI developer platform and the development ecosystem, including work item tracking, source control, CI/CD pipelines, and code review workflows, forming a coherent, automated delivery chain.
  • Build rules, instruction files, and CI pipeline checks that flag PHI exposure, tenant isolation concerns, and security issues in AI-generated code before it reaches human review.
  • Translate HIPAA/HITRUST compliance requirements into automated guardrails, using defense-in-depth controls spanning instruction files, sandbox configurations, CI checks, and human review gates.
  • Define and maintain permission tiers for AI agent operations (read-only, metadata access, code writes with approval) to maintain BAA compliance.
  • Ensure AI-assisted delivery produces auditable artifacts, including PR conventions, work item linking, and AI-usage tracking that support compliance evidence collection.
  • Secure the agent input chain by evaluating and mitigating prompt injection risks from work item descriptions, code comments, PR content, and 3rd party instructions that flow through the harness into agent context.
  • Systematically test new AI models (Claude Opus, GPT Codex, Gemini Pro, etc.) against Lirio's actual coding tasks to determine when to adopt, swap, or route differently across team workflows.
  • Maintain model routing guidance: which models are best suited for which task types (complex architecture vs. boilerplate generation vs. test writing vs. code review).
  • Monitor model quality across updates and pin versions where stability is critical.
  • Define which types of code changes AI agents can submit with minimal review vs. which require full human compliance review.
  • Establish quality gates and agent supervision practices that define what "done" looks like for AI-assisted work before it reaches human review.
  • Create and maintain branch/PR conventions for AI-assisted work (agent/<work-item-id>-<short-desc>, PR templates with work item links, AI-assisted tagging).
  • Define work item conventions (readiness criteria, acceptance criteria format, agent status tags) that structure work for both human and AI execution.
  • When AI-generated code introduces defects, vulnerabilities, or compliance issues, diagnose whether the root cause is in the instruction files, the context packaging, the model routing, or the review process.
  • Tighten guardrails and adjust workflows based on incident learnings.
  • Maintain a feedback loop between production issues and the developer platform's safety controls.
  • Build and maintain observability for the AI developer platform, tracking agent task completion rates, quality gate pass rates, cost per task, guardrail trigger frequency, and model performance trends across the team's workflows.
  • Use platform telemetry to identify where AI-assisted delivery is producing value vs. where it's creating friction, and feed those insights back into harness design, model routing, and workflow standards.
  • Provide subject matter expertise on AI-assisted development practices to engineering teams.
  • Build prototypes, reference integrations, and proof-of-concept solutions to validate platform design decisions and de-risk implementations.
  • Promote AI-assisted engineering tools and modern development practices consistent with Lirio's engineering culture.
  • Document platform architecture, workflows, integration guides, and best practices.
  • Serve as a contributing member of Lirio's Architecture Team, ensuring the AI developer platform maintains architectural coherence with the broader system.
  • Partner with Product Management and delivery leadership to shape how AI-assisted delivery integrates with planning and execution workflows.
  • Work closely with Cloud, Security, and DevOps teams to ensure the AI developer platform operates within Lirio's infrastructure and security boundaries.
  • Participate in the Engineering Council, contributing to engineering standards, patterns, and technical governance as they relate to AI-augmented delivery.

Lirio uses behavioral science and AI to improve patient engagement and health outcomes. Its Precision Nudging personalisation engine analyzes individual behaviors, communication patterns, and social/clinical context to deliver hyper-personalized messages and interventions that encourage adherence and screenings. By moving beyond demographics, it enables real-time, one-to-one outreach to sustain engagement across care journeys, partnering with health systems, payers, and provider organizations. The goal is to reduce gaps in care and lower total cost of care by guiding patients through their evolving healthcare journey.

Company Size

51-200

Company Stage

N/A

Total Funding

$33.1M

Headquarters

Knoxville, Tennessee

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Launched Precision Nudging® for Life Sciences in 2024, targeting pharma patient journeys.
  • Cone Health partnership deploys AI for hypertension and diabetes adherence in 2024.
  • BrightInsight integration yields 60% lift in disengaged diabetes patient visits.

What critics are saying

  • BrightInsight commoditizes Precision Nudging, eroding standalone value in 6-12 months.
  • IQVIA crushes life sciences expansion with superior data in 12-24 months.
  • FDA AI guidelines halt unvalidated nudges, triggering client exodus in 12-18 months.

What makes Lirio unique

  • Precision Nudging® fuses behavioral science with AI for hyper-personalized health nudges.
  • Large Behavior Model processes biometrics, SDOH, and history for tailored interventions.
  • Behavioral Reinforcement Learning agents autonomously optimize nudges at individual scale.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Lirio who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Company Match

10 paid holidays + holiday week company closure

Unlimited Paid Time Off

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

5%

2 year growth

4%
Business Wire
Feb 5th, 2026
Life sciences firms struggle with patient engagement as 70% cite adherence challenges costing $100B annually

Lirio, a behavioural science and AI platform, has released research revealing that traditional personalisation approaches in life sciences fail to improve patient engagement. The survey of over 75 life sciences executives, conducted by Sage Growth Partners, found that more than 70% identified clinical trial engagement and medication adherence as persistent challenges. The report highlights that nearly 50% of patients don't take medications as prescribed, contributing to $100 billion in annual preventable healthcare costs and 125,000 avoidable deaths. Despite growing direct-to-consumer strategies, only half of organisations use digital health technologies for patient engagement, and fewer than 3% partner with specialised vendors. The findings come as new regulations reshape pharmaceutical advertising, prompting life sciences companies to rethink patient engagement strategies beyond traditional mass messaging approaches.

Teknovation.biz
May 5th, 2025
Lirio Releases Report Titled (Re)Defining Personalization

Lirio, the Knoxville-based pioneer in the union of behavioral science and artificial intelligence to deliver better health outcomes, has released new industry findings on the significant impact that advanced health... The post Lirio releases report titled (Re)defining Personalization appeared first on Teknovation.biz.

Securities and Exchange Commission
May 2nd, 2025
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Securities and Exchange Commission
May 2nd, 2025
SEC FORM D/A

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Silverwood Partners
Feb 8th, 2024
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 4, 2024 | Silverwood Partners

Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company’s pre-money valuation at $375 million. The company is a developer of a unique multi-omics platform designed to measure biology at an unprecedented […]